Hamilelikte methylthiophenyl morpholino isobutanone kullanmaktan kaçınmalı mıyım? | VeriMom
This substance (2‑methyl‑1‑(4‑methylthiophenyl)‑2‑morpholinopropan‑1‑one; CAS 71868‑10‑5) has an EU harmonised CLP classification as Toxic for Reproduction Category 1B, H360FD (“May damage fertility. May damage the unborn child”), which places it in the highest reproductive hazard category and justifies h=3. ECHA’s supporting background/briefing documents and Annex VI entry report reproductive toxicity data from regulatory assessments (animal datasets) though a specific molecular mechanism is not fully characterised; therefore m=2 (demonstrated effect in studies). Topical cosmetic exposure data are limited and it has historically been used in non‑leave‑on products / industrial applications; in absence of quantitative dermal absorption data I score exposure as low but measurable (e=1). Sources: ECHA harmonised CLP / Annex VI recommendation and background documents, ECHA brief profile.
ECHA regulatory hazard statements
- •H360FD
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- methylthiophenyl morpholino isobutanone hamilelikte güvenli mi?
- This substance (2‑methyl‑1‑(4‑methylthiophenyl)‑2‑morpholinopropan‑1‑one; CAS 71868‑10‑5) has an EU harmonised CLP classification as Toxic for Reproduction Category 1B, H360FD (“May damage fertility. May damage the unborn child”), which places it in the highest reproductive hazard category and justifies h=3. ECHA’s supporting background/briefing documents and Annex VI entry report reproductive toxicity data from regulatory assessments (animal datasets) though a specific molecular mechanism is not fully characterised; therefore m=2 (demonstrated effect in studies). Topical cosmetic exposure data are limited and it has historically been used in non‑leave‑on products / industrial applications; in absence of quantitative dermal absorption data I score exposure as low but measurable (e=1). Sources: ECHA harmonised CLP / Annex VI recommendation and background documents, ECHA brief profile.
- methylthiophenyl morpholino isobutanone emzirirken güvenli mi?
- Harmonised H360FD (may damage fertility and the unborn child) indicates high reproductive hazard (h=3) and the regulatory dossier shows animal reproductive toxicity evidence (m=2). There are no public quantitative data on human milk transfer; exposure from typical topical cosmetic use is likely low but measurable (e=1) — breastfeeding concern derives from systemic hazard plus potential for maternal systemic exposure. Sources: ECHA harmonised classification and background documents.
- methylthiophenyl morpholino isobutanone bebek cildi için güvenli mi?
- Hazard (h=3) remains because of the substance’s harmonised H360FD reproduction/teratogenic classification. Mechanistic evidence remains regulatory/animal‑based rather than a well‑characterised molecular pathway (m=2). For infant skin (0–3 yr) exposure I increase exposure by +1 relative to adults (adult e=1 → baby e=2) because infant skin has higher surface‑area‑to‑weight and an immature barrier and there are no reliable dermal absorption data showing non‑absorbability. Together this yields higher concern for use on or near infants. Sources: ECHA harmonised CLP / background documents; PubChem substance record.
- VeriMom methylthiophenyl morpholino isobutanone nasıl puanlıyor?
- VeriMom methylthiophenyl morpholino isobutanone'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 20/100 (yüksek risk) olarak puanlar.
- Hamilelikte methylthiophenyl morpholino isobutanone yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.